Hypothalamic-pituitary-adrenal axis modulation of GABAergic neuroactive steroids influences ethanol sensitivity and drinking behavior

Dialogues in Clinical Neuroscience

Volumn 8, Issue 4, 2006, Pages 463-477

  Morrow, A Leslie ^a   Porcu, Patrizia ^a   Boyd, Kevin N ^a   Grant, Kathleen A ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Ethanol; Human; Hypothalamic pituitary adrenal axis; Monkey; Neuroactive steroid; Rat

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ALCOHOL; NEUROSTEROID; PREGNENOLONE; PROGESTERONE; STEROID;

BRAIN FUNCTION; DRINKING BEHAVIOR; DRUG MECHANISM; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEUROTRANSMISSION; NONHUMAN; REVIEW; STRESS;

ALCOHOL DRINKING; ANIMALS; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DISCRIMINATION (PSYCHOLOGY); ETHANOL; GAMMA-AMINOBUTYRIC ACID; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; PREGNENOLONE; STEROIDS;

EID: 33846230432     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (132)

1. Biggio G, Purdy RH. Neurosteroids and Brain Function. San Diego, Calif: Academic Press; 2001.
2. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 1986;232:1004-1007.
3. Morrow AL, Suzdak PD, Paul SM. Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. Eur J Pharmacol. 1987;142:483-485.
4. Morrow AL, VanDoren MJ, Penland SN, Matthews DB. The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence. Brain Res Rev. 2001;37:98-109.
5. Hosie AM, Wilkins ME, da Silva HMA, Smart TG. Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature. 2006;444:486-489.
6. Gee KW, Brinton RE, Chang WC, McEwen BS. Gamma-aminobutyric acid-dependent modulation of the chloride ionophore by steroids in rat brain. Eur J Pharmacol. 1987;136:419-423.
7. Harrison NL, Majewska MD, Harrington JW, Barker JL. Structure-activity relationships for steroid interaction with the gamma-aminobutyric acid-A receptor complex. J Pharmacol Exp Ther. 1987;241:346-353.
8. Morrow AL, Pace JR, Purdy RH, Paul SM. Characterization of steroid interactions with γ-aminobutyric acid receptor-gated chloride ion channels: evidence for multiple steroid recognition sites. Mol Pharmacol. 1990;37:263-270.
9. A receptors. Neuron. 1990;4:759-765.
10. - currents. Mol Pharmacol. 1991;39:691-696.
11. Mihalek RM, Banerjee PK, Korpi ER, et al. Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Proc Natl Acad Sci U S A. 1999;96:12905-12910.
12. Paul SM, Purdy RH. Neuroactive steroids. FASEB J. 1992;6:2311-2322.
13. A receptor by progesterone metabolites. Proc R Soc Land B Biol Sci. 1987;231:359-369.
14. Xue BG, Whittemore ER, Park CH, Woodward RM, Lan NC, Gee KW. Partial agonism by 3α,21-dihydroxy-5β-pregnan-20-one at the gamma-aminobutyric acid, receptor neurosteroid site. J Pharmacol Exp Ther. 1997;281:1095-1101.
15. Romeo E, Ströhle A, Spalletta G, et al. Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry. 1998;155:910-913.
16. Uzunova V, Sheline Y, Davis JM, et al. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A. 1998;95:3239-3244.
17. A receptors. Eur J Pharmacol. 2004;506:129-132.
18. Purdy RH, Morrow AL, Moore PH Jr, Paul SM. Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. Proc Natl Acad Sci U S A. 1991;88:4553-4557.
19. Morrow AL, Janis GC, VanDoren MJ, et al. Neurosteroids mediate pharmacological effects of ethanol: a new mechanism of ethanol action? Alcohol Clin Exp Res. 1999;23:1933-1940.
20. A receptor function after acute stress. Neuroendocrinology. 1996;63:166-172.
21. Barbaccia ML, Affricano D, Trabucchi M, et al. Ethanol markedly increases "GABAergic" neurosteroids in alcohol-preferring rats. Eur J Pharmacol. 1999;384:R1-R2.
22. Girdler SS, Straneva PA, Light KC, Pedersen CA, Morrow AL. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry. 2001;49:788-797.
23. Droogleever Fortuyn HA, van Broekhoven F, Span PN, Backstrom T, Zitman FG, Verkes RJ. Effects of PhD examination stress on allopregnanolone and cortisol plasma levels and peripheral benzodiazepine receptor density. Psychoneuroendocrinology. 2004;29:1341-1344.
24. Torres JM, Onega E. Alcohol intoxication increases allopregnanolone levels in female adolescent humans. Neuropsychopharmacology. 2003;28:1207-1209.
25. Torres JM, Ortega E. Alcohol intoxication increases allopregnanolone levels in male adolescent humans. Psychopharmacology. 2004;172:352-355.
26. Holdstock L, Penland SN, Morrow AL, De Wit H. Moderate doses of ethanol fail to increase plasma levels of neurosteroid 3α-hydroxy-5α- pregnan-20-one-like immunoreactivity in healthy men and women. Psychopharmacology. 2006;186:442-450.
27. Pierucci-Lagha A, Covault J, Feinn R, et al. Subjective effects and changes in steroid hormone concentrations in humans following acute consumption of alcohol. Psychopharmacology. 2006;186:451-461.
28. Genazzani AR, Petraglia F, Bernardi F, et al. Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J Clin Endocrinol Metab. 1998;83:2099-2103.
29. Marx CE, Stevens RD, Shampine LJ, et al. Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics. Neuropsychopharmacology. 2006;31:1249-1263.
30. Khisti RT, VanDoren MJ, O'Buckley TK, Morrow AL. Neuroactive steroid 3α-hydroxy-5α-pregnan-20-one modulates ethanol-induced loss of righting reflex in rats. Brain Res. 2003;980:255-265.
31. O'Dell LE, Alomary AA, Vallee M, Koob GF, Fitzgerald RL, Purdy RH. Ethanol-induced increases in neuroactive steroids in the rat brain and plasma are absent in adrenalectomized and gonadectomized rats. Eur J Pharmacol. 2004;484:241-247.
32. A receptors, and ethanol dependence. Psychopharmacology. 2006;186:267-280.
33. Owens MJ, Ritchie JC, Nemeroff CB. 5α-Pregnane-3α,21-diol-20- one (THDOC) attenuates mild stress-induced increases in plasma corticosterone via a non-glucocorticoid mechanism: comparison with alprazolam. Brain Res. 1992;573:353-355.
34. Patchev VK, Shoaib M, Holsboer F, Almeida OFX. The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience. 1994;62:265-271.
35. Patchev VK, Hassan AHS, Holsboer F, Almeida OFX. The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology. 1996;15:533-540.
36. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J Affect Disord. 2001;62:77-91.
37. Carroll BJ, Feinberg M, Greden JF, et al. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry. 1981;38:15-22.
38. Serra M, Pisu MG, Littera M, et al. Social isolation-induced decreases in both the abundance of neuroactive steroids and GABAA receptor function in rat brain. J Neurochem. 2000;75:732-740.
39. Matsumoto K, Pinna G, Puia G, Guidotti A, Costa E. Social isolation stress-induced aggression in mice: a model to study the pharmacology of neurosteroidogenesis. Stress. 2005;8:85-93.
40. Uzunov DP, Cooper TB, Costa E, Guidotti A. Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci U S A. 1996;93:12599-12604.
41. Marx CE, Duncan GE, Gilmore JH, Lieberman JA, Morrow AL. Olanzapine increases allopregnanolone in the rat cerebral cortex. Biol Psychiatry. 2000;47:1000-1004.
42. Barbaccia ML, Affricano D, Purdy RH, Maciocco E, Spiga F, Biggio G. Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat. Neuropsychopharmacology. 2001;25:489-497.
43. Serra M, Pisu MG, Muggironi M, et al. Opposite effects of short- versus long-term administration of fluoxetine on the concentrations of neuroactive steroids in rat plasma and brain. Psychopharmacology. 2001;158:48-54.
44. Marx CE, VanDoren MJ, Duncan GE, Lieberman JA, Morrow AL. Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents. Neuropsychopharmacology. 2003;28:1-13.
45. Pisu MG, Serra M. Neurosteroids and neuroactive drugs in mental disorders. Life Sci. 2004;74:3181-3197.
46. Schmidt PJ, Purdy RH, Moore PH, Paul SM, Rubinow DR. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab. 1994;79:1256-1260.
47. Wang M, Seippel L, Purdy RH, Backstrom T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnan-20-one. J Clin Endocrinol Metab. 1996;81:1076-1082.
48. Rapkin AJ, Morgan M, Goldman L, Brann DW, Simone D, Mahesh VB. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol. 1997;90:709-714.
49. Bicikova M, Dibbelt L, Hill M, Hampl R, Starka L. Allopregnanolone in women with premenstrual syndrome. Horm Metab Res. 1998;30:227-230.
50. Sundstrom I, Backstrom T. Patients with premenstrual syndrome have decreased saccadic eye velocity compared to control subjects. Biol Psychiatry. 1998;44:755-764.
51. Monteleone P, Luisi S, Tonetti A, et al. Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol. 2000;142:269-273.
52. Epperson CN, Haga K, Mason GF, et al. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry. 2002;59:851-858.
53. Lombardi I, Luisi S, Quirici B, et al. Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome. Gynecol Endocrinol. 2004;18:79-87.
54. Klatzkin RR, Morrow AL, Light KC, Pedersen CA, Girdler SS. Histories of depression, allopregnanolone responses to stress, and premenstrual symptoms in women. Biol Psychol. 2006;71:2-11.
55. Serra M, Pisu MG, Floris I, Cara V, Purdy RH, Biggio G. Social isolation-induced increase in the sensitivity of rats to the steroidogenic effect of ethanol. J Neurochem. 2003;85:257-263.
56. Serra M, Pisu MG, Floris I, Biggio G. Social isolation-induced changes in the hypothalamic-pituitary-adrenal axis in the rat. Stress. 2005;8:259-264.
57. Holtzman SG. Discriminative stimulus effects of drugs: relationship to potential for abuse. In: Adler MW, Cowan A, eds. Modern Methods in Pharmacology. Vol 6, Testing and Evaluation of Drugs of Abuse. New York, NY: Wiley-Liss; 1990:193-210.
58. Kelly TH, Stoops WW, Perry AS, Prendergast MA, Rush CR. Clinical neuropharmacology of drugs of abuse: a comparison of discrimination and self-report measures. Behav Cogn Neurosci Rev. 2003;2:227-260.
59. Shannon EE, Porcu P, Purdy RH, Grant KA. Characterization of the discriminative stimulus effects of neuroactive steroid pregnanolone in DBA/2J and C57BL/6J inbred mice. J Pharmacol Exp Ther. 2005;314:675-685.
60. Bowen CA, Purdy RH, Grant KA. Ethanol-like discriminative stimulus effects of endogenous neuroactive steroids: effect of ethanol training dose and dosing procedure. J Pharmacol Exp Ther. 1999;289:405-411.
61. Engel SR, Purdy RH, Grant KA. Characterization of discriminative stimulus effects of the neuroactive steroid pregnanolone. J Pharmacol Exp Ther. 2001;297:489-495.
62. Grant KA, Azarov A, Shively CA, Purdy RH. Discriminative stimulus effects of ethanol and 3α-hydroxy-5α-pregnan-20-one in relation to menstrual cycle phase in cynomolgus monkeys (Macaca fascicularis). Psychopharmacology. 1997;130:59-68.
63. Grant KA, Azarov A, Bowen CA, Mirkis S, Purdy RH. Ethanol-like discriminative stimulus effects of the neurosteroid 3α-hydroxy-5α- pregnan-20-one in female Macaca fascicularis monkeys. Psychopharmacology. 1996;124:340-346.
64. Mello NK, Mendelson JH, Lex BW. Alcohol use and premenstrual symptoms in social drinkers. Psychopharmacology. 1990;101:448-455.
65. Mello NK, Mendelson JH, King NW, Bree MP, Skupny A, Ellingboe J. Alcohol self-administration by female macaque monkeys: a model for study of alcohol dependence, hyperprolactinemia and amenorrhea. J Stud Alcohol. 1988;49:551-560.
66. Mello NK, Mendelson JH, King NW, Bree MP, Skupny A, Ellingboe J. Neuroendocrine consequences of alcohol abuse in women. Ann N Y Acad Sci. 1989;562:211-240.
67. Morrow AL, VanDoren MJ, Devaud LL. Effects of progesterone or neuroactive steroid? Nature. 1998;395:652-653.
68. VanDoren MJ, Matthews DB, Janis GC, Grobin AC, Devaud LL, Morrow AL. Neuroactive steroid 3α-hydroxy-5α-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol. J Neurosci. 2000;20:1982-1989.
69. Khisti RT, VanDoren MJ, Matthews DB, Morrow AL. Ethanol-induced elevation of 3alpha-hydroxy-5alpha-pregnan-20-one does not modulate motor incoordination in rats. Alcohol Clin Exp Res. 2004;28:1249-1256.
70. Matthews DB, Morrow AL, Tokunaga S, McDaniel JR. Acute ethanol administration and acute allopregnanolone administration impair spatial memory in the Morris water task. Alcohol Clin Exp Res. 2002;26:1747-1751.
71. Hirani K, Sharma AN, Jain NS, Ugale RR, Chopde CT. Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats. Psychopharmacology. 2005;180:267-278.
72. Hirani K, Khisti RT, Chopde CT. Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3α-hydroxy-5α-pregnan-20-one. Neuropharmacology. 2002;43:1339-1350.
73. Selye H. The anesthetic effect of steroid hormones. Proc Soc Exp Biol Med. 1941;46:116-121.
74. Selye H. The antagonism between anesthetic steroid hormones and pentamethylenetetrazol. J Lab Clin Med. 1942;27:1051-1053.
75. A receptor function and seizure susceptibility. J Neurosci. 2002;22:3795-3805.
76. Rhodes ME, Frye CA. Attenuating 5alpha-pregnane-3alpha-ol-20-one formation in the hippocampus of female rats increases pentylenetetrazole-induced seizures. Epilepsy Behav. 2005;6:140-146.
77. Khisti RT, Kumar S, Morrow AL. Ethanol rapidly induces steroidogenic acute regulatory protein expression and translocation in rat adrenal gland. Eur J Pharmacol. 2003;473:225-227.
78. Korneyev A, Costa E. Allopregnanolone (THP) mediates anesthetic effects of progesterone in rat brain. Horm Behav. 1996;30:37-43.
79. Khisti RT, Boyd KN, Kumar S, Morrow AL. Systemic ethanol administration elevates deoxycorticosterone levels and chronic ethanol exposure attenuates this response. Brain Res. 2005;1049:104-111.
80. Kraulis I, Foldes G, Traikov H, Dubrovsky B, Birmingham MK. Distribution, metabolism and biological activity of deoxycorticosterone in the central nervous system. Brain Res. 1975;88:1-14.
81. Li X, Bertics PJ, Karavolas HJ. Regional distribution of cytosolic and particulate 5alpha-dihydroprogesterone 3alpha-hydroxysteroid oxidoreductases in female rat brain. J Steroid Biochem Mol Biol. 1997;60:311-318.
82. Ford MM, Nickel JD, Phillips TJ, Finn DA. Neurosteroid modulators of GABAA receptors differentially modulate ethanol intake patterns in male C57BL/6J mice. Alcohol Clin Exp Res. 2005;29:1630-1640.
83. Finn DA, Phillips TJ, Okorn DM, Chester JA, Cunningham CL. Rewarding effect of the neuroactive steroid 3α-hydroxy-5α-pregnan-20-one in mice. Pharmacol Biochem Behav. 1997;56:261-264.
84. Janak PH, Redfern JEM, Samson HH. The reinforcing effects of ethanol are altered by the endogenous neurosteroid, allopregnanolone. Alcohol Clin Exp Res. 1998;22:1106-1112.
85. Janak PH, Michael Gill T. Comparison of the effects of allopregnanolone with direct GABAergic agonists on ethanol self-administration with and without concurrently available sucrose. Alcohol. 2003;30:1-7.
86. Roberts AJ, Heyser CJ, Cole M, Griffin P, Koob GF. Excessive ethanol drinking following a history of ethanol dependence: animal model of allostasis. Neuropsychopharmacology. 2000;22:581-594.
87. Mellon SH, Deschepper CF. Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res. 1993;629:283-292.
88. Griffin LD, Mellon SH. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci U S A. 1999;965:13512-13517.
89. Spencer RL, McEwen BS. Adaptation of the hypothalamic-pituitary-adrenal axis to chronic ethanol stress. Neuroendocrinology. 1990;52:481-489.
90. Lee S, Rivier C. Altered ACTH and corticosterone responses to interleukin-1β in male rats exposed to an alcohol diet: possible role of vasopressin and testosterone. Alcohol Clin Exp Res. 1995;19:200-208.
91. Lee S, Schmidt ED, Tilders FJ, Rivier C. Effect of repeated exposure to alcohol on the response of the hypothalamic-pituitary-adrenal axis of the rat: I. Role of changes in hypothalamic neuronal activity. Alcohol Clin Exp Res. 2001;25:98-105.
92. Devaud LL, Purdy RH, Finn DA, Morrow AL. Sensitization of γ-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal. J Pharmacol Exp Ther. 1996;278:510-517.
93. A receptors in rats. Brain Res. 1998;796:222-230.
94. Cagetti E, Pinna G, Guidotti A, Baicy K, Olsen RW. Chronic intermittent ethanol (CIE) administration in rats decreases levels of neurosteroids in hippocampus, accompanied by altered behavioral responses to neurosteroids and memory function. Neuropharmacology. 2004;46:570-579.
95. Pierucci-Lagha A, Covault J, Feinn R, et al. GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated by finasteride. Neuropsychopharmacology. 2005;30:1193-1203.
96. Romeo E, Brancati A, De Lorenzo A, et al. Marked decrease of plasma neuroactive steroids during alcohol withdrawal. J Pharmacol Exp Ther. 1996;247:309-322.
97. Romeo E, Curatolo P, di Michele F, et al. Neurosteroid alterations in mood disorders associated with alcohol withdrawal. In: Genazzani AR, Petraglia F, Purdy RH, eds. The Brain: Source and Target for Sex Steroid Hormones. 1st ed. New York, NY: The Parthenon Group; 1996:113-122.
98. Hill M, Popov P, Havlikova H, et al. Altered profiles of serum neuroactive steroids in premenopausal women treated for alcohol addiction. Steroids. 2005;70:515-524.
99. Nyberg S, Andersson A, Zingmark E, Wahlstrom G, Backstrom T, Sundstrom-Poromaa I. The effect of a low dose of alcohol on allopregnanolone serum concentrations across the menstrual cycle in women with severe premenstrual syndrome and controls. Psychoneuroendocrinology. 2005;30:892-901.
100. A receptor-mediated currents in the rat forebrain. J Neurophysiol. 2000;83:3299-3309.
101. A Receptor-Mediated Behaviors. Boca Raton, FI: CRC Press LLC; 2004.
102. Kaminski RM, Marini H, Kim W, Rogawski MA. Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia. 2005;46:819-827.
103. Porcu P, Grant KA, Green HL, Rogers LS, Morrow AL. Hypothalamic- pituitary-adrenal axis and ethanol modulation of deoxycorticosterone levels in cynomolgus monkeys. Psychopharmacology. 2006;186:293-301.
104. Porcu P, Rogers LSM, Morrow AL, Grant KA. Plasma pregnenolone levels in cynomolgus monkeys following pharmacological challenges of the hypothalamic-pituitary-adrenal axis. Pharmacol Biochem Behav. 2006;84:618-627.
105. Korneyev AY, Costa E, Guidotti A. During anesthetic-induced activation of hypothalamic pituitary adrenal axis, blood borne steroids fail to contribute to the anesthetic effect. Neuroendocrinology. 1993;57:559-565.
106. Williams KL, Broadbear JH, Woods JH. Noncontingent and response-contingent intravenous ethanol attenuates the effect of naltrexone on hypothalamic-pituitary-adrenal activity in rhesus monkeys. Alcohol Clin Exp Res. 2004;28:566-571.
107. Barr CS, Newman TK, Lindell S, et al. Early experience and sex interact to influence limbic-hypothalamic-pituitary-adrenal axis function after acute alcohol administration in rhesus macaques (Macaca mulatta). Alcohol Clin Exp Res. 2004;28:1114-1119.
108. Garcia-Closas M, Herbstman J, Schiffman M, Glass A, Dorgan JF. Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphism in pre-menopausal women. Int J Cancer. 2002;102:172-178.
109. Gatti G, Bertello P, Gurioli L, et al. Plasma testosterone, estradiol, progesterone and 17-hydroxy-progesterone responses to single-dose stimulation with human chorionic gonadotropin in chronic male alcoholics. J Endocrinol Invest. 1985;8:313-319.
110. Mendelson JH, Ogata M, Mello NK. Adrenal function and alcoholism I. Serum cortisol. Psychosom Med. 1971;33:145-157.
111. Iranmanesh A, Veldhuis JD, Johnson ML, Lizarralde G. 24-hour pulsatile and circadian patterns of cortisol secretion in alcoholic men. J Androl. 1989;10:54-63.
112. Adinoff B, Martin PR, Bone GH, et al. Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin releasing hormone and corticotropin levels in alcoholics after recent and long-term abstinence. Arch Gen Psychiatry. 1990;47:325-330.
113. Adinoff B, Risher-Flowers D, De Jong J, et al. Disturbances of hypothalamic-pituitary-adrenal axis functioning during ethanol withdrawal in six men. Am J Psychiatry. 1991;148:1023-1025.
114. Adinoff B, Ruether K, Krebaum S, Iranmanesh A, Williams MJ. Increased salivary cortisol concentrations during chronic alcohol intoxication in a naturalistic clinical sample of men. Alcohol Clin Exp Res. 2003;27:1420-1427.
115. Inder WJ, Joyce PR, Wells JE, et al. The acute effects of oral ethanol on the hypothalamic-pituitary-adrenal axis in normal human subjects. Clin Endocrinol (Oxf). 1995;42:65-71.
116. Waltman C, Blevins LSJ, Boyd G, Wand GS. The effects of mild ethanol intoxication on the hypothalamic-pituitary-adrenal axis in non-alcoholic men. J Clin Endocrinol Metab. 1993;77:518-522.
117. Hundt W, Zimmermann U, Pottig M, Spring K, Holsboer F. The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal. Alcohol Clin Exp Res. 2001;25:687-691.
118. Adinoff B, Krebaum SR, Chandler PA, Ye W, Brown MB, Williams MJ. Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent men, part 1: adrenocortical and pituitary glucocorticoid responsiveness. Alcohol Clin Exp Res. 2005;29:517-527.
119. Wand GS, Dobs AS. Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics. J Clin Endocrinol Metab. 1991;72:1290-1295.
120. Costa A, Bono G, Martignoni E, Merlo P, Sances G, Nappi G. An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics. Psychoneuroendocrinology. 1996;21:263-275.
121. Ehrenreich H, Schuck J, Stender N, et al. Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Alcohol Clin Exp Res. 1997;21:1285-1293.
122. Adinoff B, Krebaum SR, Chandler PA, Ye W, Brown MB, Williams MJ. Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent men, part 2: response to ovine corticotropin-releasing factor and naloxone. Alcohol Clin Exp Res. 2005;29:528-537.
123. Inder WJ, Joyce PR, Ellis MJ, Evans MJ, Livesey JH, Donald RA. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides. Clin Endocrinol (Oxf). 1995;43:283-290.
124. Waltman C, McCaul ME, Wand GS. Adrenocorticotropin responses following administration of ethanol and ovine corticotropin-releasing hormone in the sons of alcoholics and control subjects. Alcohol Clin Exp Res. 1994;18:826-830.
125. Wand GS, Mangold D, El Deiry S, McCaul ME, Hoover D. Family history of alcoholism and hypothalamic opiodergic activity. Arch Gen Psychiatry. 1998;55:1114-1119.
126. Hernandez-Avila CA, Oncken C, Van Kirk J, Wand GS, Kranzler HR. Adrenocorticotropin and cortisol responses to a naloxone challenge and risk for alcoholism. Biol Psychiatry. 2002;51:652-658.
127. Jackson RV, Grice JE, Hockings GI, Torpy DJ. Naloxone-induced ACTH release: mechanism of action in humans. J Pharmacol Exp Ther. 1995;285:518-526.
128. Williams KL, Ko MC, Rice KC, Woods JH. Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys. Psychoneuroendocrinology. 2003;28:513-528.
129. Witter G, Hope P, Pyle D. Tissue distribution of opioid receptor gene expression in the rat. Biochem Biophys Res Commun. 1996;218:877-881.
130. Kalra SP, Hovarth T, Naftolin F, Xu B, Pu S, Kalra PS. The interactive language of the hypothalamus for the gonadotropin releasing hormone (GnRH) system. J Neuroendocrinol. 1997;9:569-576.
131. Schuckit MA. Low level of response to alcohol as a predictor of future alcoholism. Am J Psychiatry. 1994;151:184-189.
132. Schuckit MA, Smith TL. An 8-year follow-up of 450 sons of alcoholic and control subjects. Arch Gen Psychiatry. 1996;53:202-210.